“Title To Come”
Speaker: Henry Colecraft, PhD
John C. Dalton Professor of Physiology and Cellular Biophysics
Professor of Molecular Pharmacology and Therapeutics
Interim Chair, Department of Molecular Pharmacology and Therapeutics
Columbia University, Irving Medical Center
Date: Monday, Oct. 13, 2025, 12 p.m. - 1 p.m.
Location: Roy Blunt NextGen Precision Health Building, Atkins Family Seminar Room
Register Here
About the Speaker
Henry M. Colecraft, PhD obtained his BSc in Physiology from University of London King’s College, and his PhD in Pharmacology from the University of Rochester. He completed his postdoctoral training at Johns Hopkins University, where he remained as an Assistant Professor in Biomedical Engineering till he was recruited to Columbia University as an Associate Professor in 2007.
Dr. Colecraft is an international leader in the molecular physiology of ion channel proteins that underlie signaling in nerve cells and the heart. He has directed the Ion Channel Physiology & Disease Lab since 2001. His research group has contributed seminal advances to understanding molecular mechanisms underlying regulation of voltage-dependent Ca2+ and K+ channels by accessory subunits, posttranslational modifications, and signaling molecules. His group also studies how inherited mutations in ion channels lead to devastating diseases (known as ion channelopathies) that span the cardiovascular, neurological, and respiratory systems, and in devising new therapies for them.
About the Discovery Series
The NextGen Precision Health Discovery Series provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities. The series consists of monthly lectures geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts.
For questions about this event or any others in the Discovery Series, please reach out to Mackenzie Lynch.